Latest News & Features
Americas
Pharmaceutical company Merck and Samsung Bioepis, a joint venture between South Korean firm Samsung and Biogen, have agreed to work on a diabetes treatment. 11 February 2014
Americas
The US Court of Appeals for the Federal Circuit has upheld a patent covering Pfizer’s pain drug Lyrica, closing the market to any generic challengers until 2018. 10 February 2014
Asia
Roche’s Indian subsidiary has sued Mylan and Bangalore-based pharmaceutical company Biocon at the Delhi High Court, for launching a biosimilar of its breast cancer drug Herceptin (trastuzumab). 7 February 2014
Americas
Myriad Genetics has entered into a definitive agreement to acquire inflammatory and autoimmune diagnostics company Crescendo Bioscience for $270 million. 6 February 2014
Americas
Law firm Baker & McKenzie has hired pharmaceutical lawyer Julian Thurston as a consultant in its global pharmaceutical and healthcare industry group. 5 February 2014
article
UK IP law firm Powell Gilbert has appointed solicitor and medical doctor Tess Waldron as an associate. 30 January 2014
Americas
A US medical research foundation has received about $131.2 million in damages after a jury found that two of its patents covering cochlear implants were infringed. 29 January 2014
Americas
Healthcare company Covidien PLC has been told it did not infringe patents belonging to a Johnson & Johnson-owned company through using its ultrasonic dissection device. 29 January 2014
Americas
On January 28, Teva announced that the FDA had approved its supplemental new drug application for a new formulation of its biggest selling drug Copaxone. 29 January 2014
Big Pharma
The UK High Court has decided to award Slovenian generic pharmaceutical company KRKA damages after a preliminary injunction enforced against the company by AstraZeneca was discharged. 28 January 2014